Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRC Myeloma VII: Intensive vs Standard Chemotherapy
NCT00002599Phase 3Unknown
- Sponsor
- Medical Research Council
- Start
- Sep 1994
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melphalan in multiple myeloma (MM), sponsored by Medical Research Council. Status: unknown.
02
Drugs
melphalan
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00002599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002599.